Insider Activity Highlights Leidos’ Strategic Confidence
On May 8, 2026, Gregory R. Dahlberg, a senior director at Leidos, executed a sizable purchase of 1,067 shares of the company’s common stock and immediately granted himself 1,281 stock‑options. The transaction cost was zero dollars, reflecting the exercise of a pre‑existing option that was already vested on the earlier of the first anniversary of the grant or the next annual meeting of shareholders. This move adds 24,036 shares to Dahlberg’s holdings, bringing his total position to roughly 24,000 shares—well within the 10 % ownership threshold for insiders but far enough to signal continued confidence in the company’s long‑term prospects.
Implications for Investors and Leidos’ Future Trajectory
The purchase occurs amid a broader wave of insider buying, with eight other executives (from Fubini to Shapard) each buying between 1,000 and 130,000 shares in the same week. While no single transaction shifts control, the collective pattern underscores a belief that Leidos’ valuation is still underappreciated. At a closing price of $127.68, the cumulative insider buys amount to more than $12 million in equity, suggesting that senior leadership is willing to invest significant capital even as the stock has been dragging—down 6.9 % in the week, 18.9 % in the month, and 16.6 % in the year—below its 52‑week low of $125.34. For shareholders, this alignment of interests can be reassuring, potentially tempering short‑term volatility as the company pursues its national‑security and engineering contracts.
Profile of Gregory R. Dahlberg
Dahlberg’s trading history is characterized by disciplined, option‑driven purchases. In May 2025, he acquired 1,030 options and 873 shares, totaling 21,068 shares post‑transaction. The May 2026 purchase continues that trend, with a similar volume of options and a comparable share purchase. Over the past year, Dahlberg has remained a steady, moderate‑risk insider, favoring long‑term holdings over speculative short‑term trades. His consistent buying pattern aligns with Leidos’ growth strategy—leveraging its strong footprint in national‑security contracts and expanding digital transformation services—indicating that he sees sustained upside as the company capitalizes on government demand and technological innovation.
What Should Investors Watch?
| # | Focus Area | Rationale |
|---|---|---|
| 1 | Option‑Grant Timing | The vesting schedule tied to the next annual meeting suggests Dahlberg plans to hold until that event, possibly aligning with a new dividend or capital‑raising plan. |
| 2 | Market‑wide Insider Buying | The cluster of insider purchases during a bearish trend may presage a rebound if Leidos’ contracts secure new government funding or if it successfully upsells its cloud‑based health solutions. |
| 3 | Earnings and Cash Flow | Leidos’ P/E of 11.8 remains attractive relative to its peers. Investors should monitor whether the company maintains its cash‑generating ability amid rising defense spending and potential cost overruns in its engineering projects. |
In summary, Dahlberg’s recent buy, coupled with a flurry of insider purchases, signals that Leidos’ leadership remains optimistic despite current price declines. For investors, this insider confidence—if corroborated by solid earnings and contract pipelines—could be a catalyst for a modest recovery in the stock’s valuation.
Insider Transaction Summary (May 8, 2026)
| Date | Owner | Transaction Type | Shares | Price per Share | Security |
|---|---|---|---|---|---|
| 2026‑05‑08 | Dahlberg, Gregory R. | Buy | 1,067 | N/A | Common Stock |
| 2026‑05‑08 | Dahlberg, Gregory R. | Buy | 1,281 | N/A | Stock Option (Right to Buy) |
| 2026‑05‑08 | Fubini, David G. | Buy | 1,067 | N/A | Common Stock |
| 2026‑05‑08 | Fubini, David G. | Buy | 1,281 | N/A | Stock Option (Right to Buy) |
| 2026‑05‑08 | Geer, Noel B. | Buy | 1,067 | N/A | Common Stock |
| N/A | Geer, Noel B. | Holding | 2,000 | N/A | Common Stock |
| N/A | Geer, Noel B. | Holding | 32,000 | N/A | Common Stock |
| 2026‑05‑08 | Geer, Noel B. | Buy | 1,281 | N/A | Stock Option (Right to Buy) |
| 2026‑05‑08 | Jonas, Tina W. | Buy | 1,067 | N/A | Common Stock |
| 2026‑05‑08 | Jonas, Tina W. | Buy | 1,281 | N/A | Stock Option (Right to Buy) |
| 2026‑05‑08 | KRAEMER, Harry M. Jansen Jr. | Buy | 1,067 | N/A | Common Stock |
| N/A | KRAEMER, Harry M. Jansen Jr. | Holding | 93,281 | N/A | Common Stock |
| 2026‑05‑08 | KRAEMER, Harry M. Jansen Jr. | Buy | 1,281 | N/A | Stock Option (Right to Buy) |
| 2026‑05‑08 | May, Gary Stephen | Buy | 1,067 | N/A | Common Stock |
| 2026‑05‑08 | May, Gary Stephen | Buy | 1,281 | N/A | Stock Option (Right to Buy) |
| 2026‑05‑08 | Norton, Nancy A. | Buy | 1,067 | N/A | Common Stock |
| 2026‑05‑08 | Norton, Nancy A. | Buy | 1,281 | N/A | Stock Option (Right to Buy) |
| 2026‑05‑08 | Shanahan, Patrick M. | Buy | 1,067 | N/A | Common Stock |
| 2026‑05‑08 | Shanahan, Patrick M. | Buy | 1,281 | N/A | Stock Option (Right to Buy) |
| 2026‑05‑08 | SHAPARD, Robert S. | Buy | 1,067 | N/A | Common Stock |
| N/A | SHAPARD, Robert S. | Holding | 1,625 | N/A | Common Stock |
| N/A | SHAPARD, Robert S. | Holding | 2,500 | N/A | Common Stock |
| 2026‑05‑08 | SHAPARD, Robert S. | Buy | 1,281 | N/A | Stock Option (Right to Buy) |
All transaction details are based on filings reported in the period ending May 8, 2026.




